Detalhe da pesquisa
1.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605003
2.
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.
J Med Internet Res
; 24(6): e33446, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737449
3.
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(7): 1222-1230, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495600
4.
Real-world outcomes of advanced melanoma patients not represented in phase III trials.
Int J Cancer
; 147(12): 3461-3470, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559817
5.
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 126(9): 1362, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256756
6.
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(10): 1746, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723402
7.
A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
Int J Infect Dis
; 129: 57-62, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738957
8.
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry.
Eur J Cancer
; 182: 132-143, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773402
9.
Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.
J Immunother
; 46(5): 197-204, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103470
10.
Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Support Care Cancer
; 20(1): 107-17, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21258948
11.
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.
Melanoma Res
; 32(6): 460-468, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703270
12.
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.
JCO Oncol Pract
; 18(10): e1611-e1620, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944229
13.
Cancer-related fatigue: clinical practice versus practice guidelines.
Support Care Cancer
; 19(4): 531-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20238129
14.
Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status.
Am J Clin Oncol
; 44(2): 82-89, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332931
15.
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.
Melanoma Res
; 31(1): 58-66, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351553
16.
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
Cancers (Basel)
; 13(20)2021 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680228
17.
Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
Eur J Cancer
; 158: 234-245, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34600790
18.
Level of agreement between patient self-report and observer ratings of health-related quality of life communication in oncology.
Patient Educ Couns
; 65(1): 95-100, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16872790
19.
Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study.
Cancer
; 113(3): 628-37, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18543317